Skip to main content

Roche’s Virtual Neurology Investor Event

Roche has hosted a virtual event on 11th March 2024.

Agenda
WelcomeBruno Eschli, Head of Investor Relations
Neurology franchise updatePaulo Fontoura, Senior Vice President and Global Head of Neuroscience, Immunology, Ophthalmology, Cardiometabolic, Infectious and Rare Diseases Clinical Development
Review of key EMBARK data presented at MDAAlex Murphy, Senior Clinical Director
Review of key trotinemab and prasinezumab data presented at AD/PDAzad Bonni, MD, PhD, Senior Vice President and Global Head of Neuroscience & Rare Diseases, Roche Pharma Research & Early Development
Questions and answers

Webinar Replay

InvestorsPast IR Events
View more Events, Past IR Events

Discover more

  • Governance

    About Roche

    Our corporate governance principles focus on sustainable value creation and promote a culture that recognises standards of good corporate governance and a commitment to transparent communication.

  • Product Development Pipeline

    Solutions

    Discover our pipeline of Pharmaceutical and Diagnostics developments

  • Frequently asked questions

    Investors

    We answer the Roche investors-related most frequently asked questions

  • Finance Information Tool

    Investors

    Access the finance information tool for the latest Roche financial data.